Anti-Acid Meds Lower Strength of Systemic Sclerosis Drug Anti-Acid Meds Lower Strength of Systemic Sclerosis Drug

Weakened bioavailability of mycophenolate mofetil could require adjustments in treatment.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Source Type: news